Get started
Author

Parthiban Brindha Devi

Observed names: Brindha Devi, Brindha Devi P, Brindha Devi Parthiban, BrindhaDevi Parthiban, Parthiban Brindhadevi
Institution: Vels University
ORCID: 0000-0003-2859-4659
Observed ORCID: 0000-0003-2859-4659
OpenAlex ID: A5031972537
Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease
2020 · Shivanika C, Deepak Kumar S., et al. · Journal of Biomolecular Structure and Dynamics · 432
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors
2016 · Ganesh Samala, Parthiban Brindha Devi, et al. · Bioorganic & Medicinal Chemistry · 69
Identification of novel inhibitors against Mycobacterium tuberculosis l-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening
2013 · Shalini Saxena, Parthiban Brindha Devi, et al. · Journal of Molecular Graphics and Modelling · 39
Design and development of novel Mycobacterium tuberculosis l-alanine dehydrogenase inhibitors
2014 · Shalini Saxena, Ganesh Samala, et al. · European Journal of Medicinal Chemistry · 36
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: Molecular hybridization from known antimycobacterial leads
2014 · Ganesh Samala, Parthiban Brindha Devi, et al. · Bioorganic & Medicinal Chemistry · 35
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors
2013 · Ganesh Samala, Parthiban Brindha Devi, et al. · European Journal of Medicinal Chemistry · 34
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors
2014 · Ganesh Samala, Radhika Nallangi, et al. · Bioorganic & Medicinal Chemistry · 33
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis
2014 · Ganesh S. Pedgaonkar, Jonnalagadda Padma Sridevi, et al. · European Journal of Medicinal Chemistry · 31
Structure‐Guided Design of Thiazolidine Derivatives as Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors
2014 · Parthiban Brindha Devi, Ganesh Samala, et al. · ChemMedChem · 30
A Review on Dna Nanobots – a New Technique for Cancer Treatment
2018 · Devasena Umai R, Brindha Devi P, et al. · Asian Journal of Pharmaceutical and Clinical Research · 24
PDF
Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus
2014 · Renuka Janupally, Variam Ullas Jeankumar, et al. · Bioorganic & Medicinal Chemistry · 24
Design and Biological Evaluation of Furan/Pyrrole/Thiophene‐2‐carboxamide Derivatives as Efficient DNA GyraseB Inhibitors ofStaphylococcus aureus
2015 · Renuka Janupally, Bhramam Medepi, et al. · Chemical Biology & Drug Design · 23
Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities
2015 · Parthiban Brindha Devi, Sridhar Jogula, et al. · Molecular Informatics · 21
Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis
2015 · Parthiban Brindha Devi, Jonnalagadda Padma Sridevi, et al. · Tuberculosis · 17
Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis
2016 · Ganesh Samala, Parthiban Brindha Devi, et al. · Bioorganic & Medicinal Chemistry · 14
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA
2014 · Ganesh S. Pedgaonkar, Jonnalagadda Padma Sridevi, et al. · Bioorganic & Medicinal Chemistry · 12
Investigating structure–activity relationship and mechanism of action of antitubercular 1-(4-chlorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrobenzylidene) pyrazolidine-3,5-dione [CD59]
2014 · Ganesh Samala, Shruti Singh Kakan, et al. · International Journal of Mycobacteriology · 9
Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation
2015 · Priyanka Suryadevara, Perumal Yogeeswari, et al. · Current Topics in Medicinal Chemistry · 8
A Review on Protein Tyrosine Phosphatases - an Important Target for Various Diseases
2018 · Venkataraghavan R, Brindha Devi P, et al. · Asian Journal of Pharmaceutical and Clinical Research · 6
PDF
A Review on Artificial Blood: a Source We Need
2017 · Krishna Veni R, Brindha Devi P, et al. · Asian Journal of Pharmaceutical and Clinical Research · 6
PDF
Docking Studies for Various Antibacterial Benzilate Derivatives
2017 · Sudha Rajendran, Brindha Devi P, et al. · Asian Journal of Pharmaceutical and Clinical Research · 4
PDF
Docking Antioxidant Activity on Hydroxy (diphenyl) Aceticacid and Its Derivatives
2017 · Sudha Rajendran, Nithya G, et al. · Asian Journal of Pharmaceutical and Clinical Research · 3
PDF
Corrigendum to “Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus” [Bioorg. Med. Chem. 22 (2014) 5970–5987]
2015 · Renuka Janupally, Variam Ullas Jeankumar, et al. · Bioorganic & Medicinal Chemistry · 2
Assessment of furobenzopyran from Ammi visnaga in disrupting Pseudomonas aeruginosa biofilms and suppressing associated virulence factors
2025 · Rajendra Moorthy Rajendran, Parthiban Brindha Devi · Microbial Pathogenesis · 1
Furobenzopyrans from Ammi visnaga suppress Pseudomonas aeruginosa virulence
2025 · Rajendra Moorthy Rajendran, Parthiban Brindha Devi · Journal of Applied Biology & Biotechnology · 1
PDF
Works count: 39
Citation count: 918
H-index: 14
I10-index: 16
Year
Topic
Type